.... We conclude that patients with Ph 1 -positive lymphoblastic leukemia have a disease that is resistant to treatment that is highly effective in patients with Ph 1 -negative ALL. 3 10 1988 9 11 1988 24 2 2009 Short Communication Acta Haemat 1989;81:217-218 (g) 1989 S. K arger A G...

... uncontrolled thrombocytosis after 3 years of interferon-α treatment, the patient received imatinib at a dosage of 400 mg/day. Though achieving a sustained and complete hematological response after 3 months, she was resistant to imatinib during the entire 65-month imatinib treatment. That is, she failed...

... 1.6 ± 0.5 g/dl). In 6 patients, resistance to rhEPO was noted (mean Hb increase 0.5 ± 0.5 g/dl). The mean gestational age at the start of therapy was 28 weeks of gestation and at the end 32 weeks. The mean duration of a complete therapy was 3.5 weeks (range 2–4.5 weeks). If calculated for body weight...